New York, NY -- (SBWIRE) -- 12/11/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Vitran Corporation, Inc. (USA) (NASDAQ:VTNC), Evertec Inc (NYSE:EVTC), Applied DNA Sciences Inc (OTCMKTS:APDN), Twitter Inc (NYSE:TWTR)
Vitran Corporation, Inc. (USA) (NASDAQ:VTNC) showed a volume of 3.65 million shares by the end of last trade whereas the average volume of the stock remained 49,842.00 shares. The stock opened the session at $6.02 but then moved to $6.04. At that price, the stock showed a positive performance of 11.03%. Vitran Corporation Inc. (Vitran) is a provider of freight surface transportation and related supply chain services throughout Canada 34 states in the eastern, southeastern, central, southwestern, and western United States. The Company’s business consists of Less-than-truckload services (LTL). These services are provided by stand-alone business units within their respective regions.
Will VTNC Continue To Move Higher? Find Out Here
Evertec Inc (NYSE:EVTC) opened the session at $22.56 and closed the session at $22.74. The stock showed a positive performance of 7.72% in previous trading session. EVERTEC, Inc. (EVERTEC), formerly Carib Latam Holdings, Inc., is a full service transaction processing business in Latin America and the Caribbean. The Company provides a range of merchant acquiring, payment processing and business process management services across 19 countries in the region. It processes over 1.8 billion transactions annually, and manages the electronic payment network for over 4,100 automated teller machines (ATM) and over 104,000 point-of-sale payment terminals.
For How Long EVTC will fight for Profitability? Read This Trend Analysis report
Applied DNA Sciences Inc (OTCMKTS:APDN) opened the session at $0.13 and closed the session at $0.136. The stock showed a positive performance of 8.97% in previous trading session. Traded with volume of 3.79 million shares in the prior session and the average volume of the stock remained 1.51 million shares. The beta of the stock remained 1.46. Applied DNA Sciences, Inc. is a provider of botanical-deoxyribonucleic acid (DNA) based security and authentication solutions that can help protect products, brands and property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature DNA, Cashield, DNANet and BioMaterial Genotyping, its anti-counterfeiting and product authentication solutions, are used in industries, including cash-in-transit (transport and storage of banknotes).
Why Should Investors Buy APDN After The Recent Gain? Just Go Here and Find Out
Twitter Inc (NYSE:TWTR) the stock advanced 5.80% and finished the session at $51.99. Traded with volume of 2,609.00 shares in the prior session and the average volume of the stock remained 14.95 million shares. Twitter, Inc. (Twitter) is a global platform for public self-expression and conversation in real time. Twitter is a real-time platform, where any user can create a Tweet and any user can follow other users. Each Tweet is limited to 140 characters of text, but can also contain rich media, including photos, videos and applications. The Company offers Twitter apps for phones, tablets and computers. The Company generates its advertising revenue primarily from the sale of its three Promoted Products:
Will TWTR Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)